Business
A report on The Economist Group Africa Summit 2013 Conference – Dr. Castano of Nano Labs Corp.
“Following up on business development opportunities uncovered at the African conference will be a top priority for Nano Labs and we are very excited about the relationships that were established in London last week,” concluded Dr. Castano. “We look forward to updating our shareholders in the near future.”
About Nano Labs: Nano Labs Corporation is a nanotechnology research and development company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material.
The Company’s research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place.
Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us.
Forward looking statements
This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws.
These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company’s news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.
Contact:
Contact Nano Labs Corp.
Bernardo Camacho Chavarria
President
1 (888) 806-2315
